Filing Details
- Accession Number:
- 0001209191-20-008136
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-02-10 20:02:15
- Reporting Period:
- 2020-02-06
- Accepted Time:
- 2020-02-10 20:02:15
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1308547 | Dolby Laboratories Inc. | DLB | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1200469 | J Kevin Yeaman | C/O Dolby Laboratories, Inc. 1275 Market Street San Francisco CA 94103 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Class A Common Stock | Acquisiton | 2020-02-06 | 50,000 | $33.15 | 82,895 | No | 4 | M | Indirect | By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 |
Class A Common Stock | Disposition | 2020-02-06 | 50,000 | $72.00 | 32,895 | No | 4 | S | Indirect | By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 |
Class A Common Stock | Acquisiton | 2020-02-07 | 5,000 | $33.15 | 37,895 | No | 4 | M | Indirect | By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 |
Class A Common Stock | Disposition | 2020-02-07 | 5,000 | $71.08 | 32,895 | No | 4 | S | Indirect | By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Indirect | By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 |
No | 4 | S | Indirect | By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 |
No | 4 | M | Indirect | By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 |
No | 4 | S | Indirect | By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Class A Common Stock | Employee Stock Option (right to buy) | Disposition | 2020-02-06 | 50,000 | $0.00 | 50,000 | $33.15 |
Class A Common Stock | Employee Stock Option (right to buy) | Disposition | 2020-02-07 | 5,000 | $0.00 | 5,000 | $33.15 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
43,218 | 2022-12-15 | No | 4 | M | Indirect | |
38,218 | 2022-12-15 | No | 4 | M | Indirect |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Class A Common Stock | 107,388 | Direct |
Footnotes
- The shares were sold in multiple transactions at prices ranging from $71.66 to $72.25, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
- The shares were sold in multiple transactions at prices ranging from $71.01 to $71.31, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
- Shares held following the reported transactions include 107,388 restricted stock units, which are subject to forfeiture until they vest.
- This performance-based stock option award was granted for a total of 97,199 shares of Class A Common Stock at target. The number of shares actually earned and vested upon the achievement of total shareholder return performance criteria measured during a three-year performance period ended on December 15, 2018 was at 125% of target, or 121,498 shares.